Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
Cittelly DM, Dimitrova I, Howe EN, Cochrane DR, Jean A, Spoelstra NS, Post MD, Lu X, Broaddus RR, Spillman MA, Richer JK.
Cittelly DM, et al. Among authors: post md.
Mol Cancer Ther. 2012 Dec;11(12):2556-65. doi: 10.1158/1535-7163.MCT-12-0463. Epub 2012 Oct 16.
Mol Cancer Ther. 2012.
PMID: 23074172
Free PMC article.